-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Alzheimer's disease (AD) is a progressive neurodegenerative disease that mainly affects the elderly.
Microgliosis and neuronal death exist in mice with hereditary TGFβ deficiency.
Consistent with the positive correlation between AD risk and aging, when systemic inflammation increases, the progression of the disease also depends on peripheral inflammation and the activation of innate immune cells.
immunity
The main products of B cells, non-specific immunoglobulin and Aβ specific antibodies can provide neuroprotection.
Currently, the function of B cells in Alzheimer's disease (AD) is not fully understood.
Recently, researchers have discovered that AD is related to the accumulation of activated B cells in the circulation, as well as the infiltration of B cells into the brain parenchyma, leading to the deposition of immunoglobulin around Aβ plaques.
Loss of B cells can reduce the burden of Aβ plaques and microglial activation in the hippocampus of AD mice
Loss of B cells can reduce the burden of Aβ plaques and microglia activation in the hippocampus of AD mice.Loss of B cells alone is sufficient to reduce the burden of Aβ plaques and disease-related microglia.
Original source:
Original source:Ki Kim et al.
Ki Kim et al.
Leave a message here
